Bayer’s Monsanto Legacy: Stock Outlook, Earnings Surprise, and Analyst Upgrades
Bayer (ETR: BAYN) faces a critical inflection point eight years after its $63 billion acquisition of Monsanto, as debt costs rise, antitrust scrutiny intensifies, and agricultural margins tighten. With the ... Read More